Silent nephritis in systemic lupus erythematosus

Abstract

Silent lupus nephritis (SLN) was investigated in 42 renal asymptomatic patients and compared with 49 untreated patients with overt lupus nephropathy (OLN). Urinary sediment, quantitative proteinuria, creatinine clearance, antinuclear antibodies (ANA), complement, circulating immune complexes (CIC) and renal biopsies were evaluated in all of the patients. Forty-one out of the 42 (97.6%) patients had SLN according to histopathological findings. Results showed that the mean age, female=male ratio and the clinical activity index (SLEDAI) were similar in both groups (P > 0.05). The prevalence of ANA, anti-ds DNA, anti-ENA autoantibodies and C4 serum levels showed no statistical differencesbetween the two groups (P > 0.05). Conversely, in the OLN group, elevated CIC and diminished CH₅₀ and C3 serum levels were significantly different (P < 0.01). WHO class II was the predominant renal lesion in the group with SLN (P < 0.0001), whereas class IV was in the OLN patients (P < 0.0001).

We conclude that, in our series, SLN was highly prevalent in renal asymptomatic patients with otherwise systemic lupus erythematosus. Furthermore, abnormal levels of CIC, CH₅₀ and C3 associated with WHO class II suggest a moderate but ongoing activation of immune-mediated renal injury mechanisms.

Keywords

lupus nephritis overt lupus nephropathy systemic lupus erythematosus silent lupus nephritis

Get full access to this article

View all access options for this article.

References

Lee SH , Mujais SK , Kasinath BS et al. Course of renal pathology in patients with Systemic Lupus Erythematosus . Am J Med 1984; 77: 612-620 .

Balow JE , Boumpas DT , Austin HA III. Renal disease. In: Schur PH (ed.). The Clinical Management of Systemic lupus erythematosus. Lippicontt-Raven: Philadelphia, PA , 1996, pp 109-126.

Kotzin BL , West SG. Systemic lupus erythematosus. In: Clinical Immunology: Principles and Practice. Mosby: London , 2001, 1-24.

Ahmadian YS , Given GZ , Mendoza SA. Normal urine and positive immunofluorescence reaction in lupus nephritis . Am J Dis Child 1972; 123: 121-125 .

Mahajan SK , Ordoñez NG , Freitelson PJ et al. Lupus nephropathy without clinical renal involvement . Medicine (Balt) 1977; 56: 493-501 .

D’Agati VD. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjögren’s syndrome, and rheumatoid arthritis. In: Jennette JCh , Olson JL , Schwartz MM , Silva FG (eds). Heptinstall’s Pathology of the Kidney. Lippincott-Raven: Philadelphia, PA , 1998, pp 541-624.

Perez-Rojas G , Suarez-Chacón R , Penchaszadeh G et al. Pathophysiology of the immune response in systemic lupus erythematosus: a new approach . In: Zabrieskie J (ed.). Proceedings of Streptococcal Diseases and Immune Response. Academic Press, New York, 1980, pp 507-519 .

Appel GB , Silva FG , Pirani CI et al. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification . Medicine (Balt) 1978; 57: 371-410 .

Ginzler EM , Nicastri AD , Chen CK et al. Progression of mesangial and focal to diffuse lupus nephritis . New Engl J Med 1974; 291: 693-696 .

10.

Mahajan SK , Ordoñez NG , Spargo BH et al. Changing histopathology patterns in lupus nephropathy . Clin Nefrol 1978; 10: 1-8 .

11.

Morel-Maroger L , Méry JP , Droz D et al. The course of lupus nephritis: contribution of serial renal biopsies. In: Hamburger J , Crosnier J , Maxwell MH (eds). Advances in Nephrology. Year Book Medical: Chicago, IL , 1976, pp 79-118.

12.

Lentz RD , Michael AF , Friend PS. Membranous transformation of lupus nephritis . Clin Immunol Immunopathol 1981; 19: 131-136 .

13.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25 (11): 1271-1277 .

14.

Bombardier C , Gladman DD , Urowitz MB and the Committee on prognosis studies in SLE . Derivation of the SLEDAI. A disease activity index for lupus patients . Arthritis Rheum 1992; 35 (6): 630-640 .

15.

Ter Borg EJ , Horst G , Hummel EJ et al. Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus; a long-term prospective study . Arthritis Rheum 1990; 33: 634-643 .

16.

Towbin H , Sthaelin T , Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications . Proc Natl Acad Sci USA 1979; 76: 4350-4354 .

17.

Mc Duffie FC , Byrd MG , Dougal JS et al. Immunodiffusion assay for detection of antibodies to Sm, U1-RNP, SSA=Ro, SSB=La, SCl-70 and Jo 1. In: Cavallaro JJ , Mc Duffie FC , Byrd MG , Mc Dougal JS (eds). Laboratory Methods for Detection of Antinuclear Antibodies. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control , 1987, pp 105-136.

18.

Orozco A , Sánchez P , Bianco NE et al. Solid phase C1q microassay for the rapid detection of circulating immunocomplexes . J Immunol Meth 1983; 59: 237-243 .

19.

Kent JF , Fife EH. Precise standardization of reagents in complement assays . Am J Trop Med Hyg 1963; 12: 103-106 .

20.

Schwartz MM. The pathologic diagnosis of renal disease. In: Jennette JCh , Olson JL , Schwartz MM , Silva FG (eds). Heptinstall’s Pathology of the Kidney. Lippincott-Raven: New York , 1998, pp 169-180.

21.

Churg J , Bernstein J , Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases: Lupus Nephritis. Igaku-Shoin: New York , 1995, pp 151-156.

22.

Ingelfinger JA , Mosteller F , Thibodeau LA , Ware JH. Biostatistics in Clinical Medicine. Mc Graw Hill: New York , 1994, p 418-418.

23.

McLaughlin JR , Gladman DD , Urowitz MB et al. Kidney biopsy in systemic lupus erythematosus. II. Survival analysis according to biopsy results . Arthritis Rheum 1991; 34: 1268-1273 .

24.

Cameron JS. Disease of the month: lupus nephritis . J Am Soc Nephrol 1999; 10: 413-424 .

25.

Pollak VE , Pirani CL. Lupus Nephritis. Pathology, pathogenesis, clinicopathologic correlation and prognosis. In: Wallace DJ , Hannahs Hahn B (eds). Dubois’ Lupus Erythematosus. Lea & Febiger: Philadelphia, PA , 1993, pp 525-541.

26.

Hermann M , Winller T , Gaipl U et al. Etiopathogenesis of systemic lupus erythematosus . Int Arch Allergy Immunol 2000; 123: 28-35 .

27.

Mohan C , Datta SK. Short analytical review. Lupus: key pathogenic mechanism and contributing factors . Clin Immunol Immunopathol 1995; 77 (3): 209-220 .

28.

Arbuckle MR , James JA , Kohlhase KF et al. Development of anti-ds DNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus . Scand J Immunol 2001; 54: 211-219 .

29.

Tápanes FJ , Vásquez M , Ramirez R et al.

Cluster analysis of anti-nuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable antinuclear antibodies protective?

Lupus 2000; 9: 437-444 .

30.

Huong TDL , Papo T , Beaufils H et al. Renal involvement in Systemic Lupus Erythematosus: a study of 180 patients from a single center . Medicine 1999; 78: 148-166 .

31.

Falk RJ. Editorial: Treatment of lupus nephritis. A work in progress . New Engl J Med 2000; 343 (16): 1182-1183 .

32.

Austin HA III , Boumpas DT , Vaughn EM et al. Predicting renal outcomes in severe lupus nephritis. Contributions of clinical and histologic data . Kidney Int 1994; 45: 544-550 .

33.

Donadio JV jr , Hart GM , Bergstralh EJ et al. Prognostic determinants in lupus nephritis. A long-term clinic-pathologic study . Lupus 1995; 4: 109-115 .

34.

Nossent H , Berden J , Swaak T. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis . Lupus 2000; 9 (7): 504-510 .

35.

Gonzalez-Crespo MR , López-Fernández JL , Usera G et al. Outcome of silent nephritis . Sem Arthritis Rheum 1996; 26: 468-476 .